Micreos
Micreos, a Wageningen, The Netherlands-based developer of phage technology for targeted control of bacteria.
Total raised
€87M
€87,000,000
Funding rounds
3
Investors
0
distinct backers
Active since
2019-03
latest 2022-10
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood20
base rate 30% for Other
- ▼ Overdue vs cohort gap
- ▼ Down/flat last round
Exit likelihood19
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
- ▲ €30M+ raised
- ▲ 20y since founding
Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-10-25 | Other | €25M | — | View deal → |
| 2021-10-01 | Other | €32M | — | View deal → |
| 2019-04-01 | Other | €30M | — | View deal → |
Related news
- Micreos Secures €25M in Growth Fundingfinsmes.com · 2022-10
- Micreos Raises €32M in Fundingfinsmes.com · 2021-10
- nutraingredients.com
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- Roivant Sciences€1.2BSwitzerland · Healthtech